Drivers and Trajectories of Resistance to New First-Line Drug Regimens for Tuberculosis

BACKGROUND:  New first-line drug regimens for treatment of tuberculosis (TB) are in clinical trials: emergence of resistance is a key concern. Because population-level data on resistance cannot be collected in advance, epidemiological models are important tools for understanding the drivers and dyna...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Open Forum Infect Dis
Asıl Yazarlar: Shrestha, Sourya, Knight, Gwenan M., Fofana, Mariam, Cohen, Ted, White, Richard G., Cobelens, Frank, Dowdy, David W.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Oxford University Press 2014
Konular:
Major Articles
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4281792/
https://ncbi.nlm.nih.gov/pubmed/25734143
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofu073
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller